Trusted by Industry Leaders
GMPKit serves pharmaceutical manufacturers across North America, Europe, and Asia—helping reduce Cost of Poor Quality and restore operational stability.
Global Reach, Local Execution
Our team has delivered results across multiple continents—applying proven operational discipline directly alongside site leadership inside GMP-regulated manufacturing environments.
Client locations shown. Identities and engagement details are kept confidential.
What Our Clients Experience
Across engagements, we consistently see improvements in the following areas. Client identities and specific results remain confidential—our clients operate in high-sensitivity environments and we do not publicly disclose engagement details.
Deviation Backlog Reduction
Structured investigation frameworks and clearer ownership systems reduce open deviation counts and aging records within the first engagement cycle.
Batch Disposition Timelines
Clearer decision criteria, better record readiness, and resolved bottlenecks accelerate batch release without introducing compliance risk.
Schedule Adherence
Improved batch flow, cleaner handoffs, and fewer surprise escalations translate into more predictable manufacturing schedules.
Capacity Recovery
Reducing time lost to avoidable failures, rework, and deviation investigation frees production capacity that was previously invisible.
Execution Stability
Sites move from reactive firefighting to predictable, governed execution—with results that hold after the engagement ends.
Scale-Up Readiness
Strengthened operational foundations prepare sites to absorb increased volume, new products, or regulatory scrutiny without destabilizing.
"Our engagements typically begin in high-stakes situations—batch loss, deviation backlogs, inspection risk. We don't publicize the details. We focus on whether execution is stable when we leave."
— GMPKit Team
Industries We Serve
We bring deep expertise across pharmaceutical manufacturing environments, from traditional small molecules to advanced biologics and cell therapies.
Pharmaceutical Manufacturing
Biotechnology
CDMO/CMO
Biologics
Ophthalmological
Aseptic Manufacturing
Cell Therapy
Ready to Join Our Client Partners?
If you're facing batch failures, deviation backlogs, or inspection findings—schedule a diagnostic call to discuss where COPQ is being generated and what to correct first.